Friedberg Robert D, Bayar Hasan
Dr. Friedberg is with the Center for the Study and Treatment of Anxious Youth, Palo Alto University, Palo Alto, California (e-mail:
Psychiatr Serv. 2017 Jun 1;68(6):621-623. doi: 10.1176/appi.ps.201600153. Epub 2017 Jan 17.
The emergence of evidence-based psychological treatments (EVPTs) is a scientific success story, but unfortunately the application of these empirically supported procedures has been slow to gain ground in treatment-as-usual settings. This Open Forum commentary argues that direct-to-consumer (DTC) marketing, which has worked well in communicating the advantages of various medicines, should perhaps be considered for use in social marketing of EVPTs. DTC marketing of pharmaceuticals is a long-standing advertising strategy in the United States. In fact, DTC marketing of psychotropic medicines is quite a success story. The authors recommend various strategies for using marketing science to devise DTC advertising of EVPTs, discuss previous research on DTC campaigns, and describe initiatives launched in the United Kingdom and Europe to promote EVPTs. Suggestions for evaluating and regulating DTC marketing of EVPTs are included. Finally, the potential for DTC marketing of EVPTs to increase mental health literacy and reduce health disparities is explored.
循证心理治疗(EVPTs)的出现是一个科学上的成功案例,但不幸的是,这些经验证有效的治疗方法在常规治疗环境中的应用进展缓慢。这篇开放论坛评论认为,在宣传各类药物优势方面效果良好的直接面向消费者(DTC)营销,或许应被考虑用于EVPTs的社会营销。药品的DTC营销在美国是一种长期的广告策略。事实上,精神药物的DTC营销堪称一个成功案例。作者们推荐了运用营销科学设计EVPTs的DTC广告的各种策略,讨论了此前关于DTC活动的研究,并描述了英国和欧洲为推广EVPTs而发起的倡议。文中还包含了评估和监管EVPTs的DTC营销的建议。最后,探讨了EVPTs的DTC营销在提高心理健康素养和减少健康差距方面的潜力。